media – Page 7 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Plans unveiled by FDA for augmenting competition in drug markets

With the unveiling of a new drug price plan by the Trump Administration, the Food and Drug Administration (FDA) will put into action a plan to infuse competition in drug markets.
- Source: Ddu
- 80
- May 16, 2018
Remote eICU program launched to monitor patients health in US Hospitals

Providing an advanced technological paradigm to patient monitoring practices, a telemedicine platform has been launched in Australia. The remote intensive care partnership will enable doctors and nurses at the Royal Perth Hospital on the western coast of Australia to explore telemedicine technology to assess patient health in US hospitals that form part of the hub-and-spoke telehealth network of Emory.
- Source: Ddu
- 133
- May 16, 2018
digital health New Approvals Telemedicine
Amsterdam airport to be a new site for EU CAR-T manufacturing facility of Gilead

When it comes to manufacturing CAR T drugs (personalized treatments engineering immune cells to destroy cancer cells of patients) speed is of utmost importance. A new manufacturing site has been decided upon by Gilead for Yescarta, its CAR-T therapy at a Netherlands airport.
- Source: drugdu
- 160
- May 16, 2018
cancer CAR T-cells FDA New Approvals
Security issues with Philips, GE, and Silex medical devices

Serious security flaws were discovered in Philips, GE and Silex medical devices that, if exploited, could allow authorized access and let a hacker obtain elevated privileges, according to two separate U.S. Department of Homeland Security ICS-CERT alerts issued this month.
- Source: HealthIT news
- 89
- May 15, 2018
Company Insights cybersecurity medical device
Integration of next-generation sequencing data in clinical trials facilitated by DNAnexus

A clinical trial solution has been unveiled by DNAnexus that facilitates the integration of genomics data sourced from next-generation sequencing (NGS) into clinical studies. A cloud-based genomic data collection platform is offered by DNAnexus.
- Source: Ddu
- 140
- May 15, 2018
Company Insights digital health
Experimental Merck vaccine gears up to fight Congo Ebola outbreak

As the Democratic Republic of Congo deals with a rising death toll owing to the latest outbreak of Ebola, health officials are moving fast to counter the fatal effects of the deadly virus. Plans are afoot to implement the experimental vaccine developed by Merck & Co to confront the overwhelming challenges posed by the virus.
- Source: Ddu
- 188
- May 15, 2018
Ebola Merck New Approvals vaccines
New Telemedicine law legislated by Kansas

A broader law defining at greater lengths the terms telemedicine and telehealth has been signed by Jeff Coyler, Kansas Governor. Apart from setting guidelines for coverage parity, the law has stipulated a ban on abortions by telemedicine. The law also includes a mandatory rule stating that if a judge dismisses that particular clause, the whole law stands nullified.
- Source: Ddu
- 152
- May 15, 2018
digital health Policies Telemedicine USA
Qventus raised $30M investment from Bessemer Venture Partners

Mountain View, California startup - Qventus a healthcare management tech platform which uses artificial intelligence to improve hospital workflow, closed at $30 million in series B funding which will be used to expand its platform. The funding was led by Bessemer Venture Partners along with few other participants. Including this latest funding, Qventus bagged total $43 million.
- Source: Ddu
- 133
- May 15, 2018
AI Company Insights digital health
Huge biologics plant planned to be built by Sinobioway Biomedicine

Plans are afoot at Shandong Sinobioway Biomedicine Co. in China to construct a huge biologics plant as the country moves towards cell-based drugs.
- Source: drugdu
- 139
- May 15, 2018
biopharmaceutical China Market Views
Personalized Cancer Vaccine Looks Promising in Early Study

Researchers at the Perelman School of Medicine and the Abramson Cancer Center, at the University of Pennsylvania, developed the vaccine using dendritic cells (DCs) derived from each patient's own peripheral blood mononuclear cells. These dendritic cells were then exposed to the patient's tumor cells, activated with interferon gamma, and injected into the patient's lymph nodes.
- Source: Clinical Advisor
- 77
- May 15, 2018
anti-cancer cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

Market Reportsmore

China’s Import and Export Market Report of Diabetes Drugs

May 4, 2018
China’s Import and Export Market Report of Vitamins

April 11, 2018
China’s Import and Export Market Report of Contraceptive Drugs

March 16, 2018
Ddu College — China’s Import and Export Report of Peptic Ulcer Drugs

January 25, 2018
China’s Import and Export Report of External Use Otology Drugs

January 12, 2018

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.